Merck’s end-stage studies meet efficacy goal of suppressing HIV-1 virus
US-based Merck Inc., two late-stage studies have met the main efficacy goal of suppressing the HIV-1 virus in adults receiving different antiretroviral therapies,
HQ Team December 19, 2024: Recent studies have revealed a significant relationship between food allergies and atopic dermatitis (AD) in pediatric patients, indicating
Bharti Jayshankar December 19, 2024: The U.S. Food and Drug Administration (FDA) has issued a black box warning for Veozah, a medication designed
HQ Team December 18, 2024: Self-administered test for human papillomavirus, HPV, can help women self screen for risk of cervical cancer, according to
HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial
HQ Team December 17, 2024: In a study conducted in Churchill, Manitoba—often dubbed the “Polar Bear Capital of the World”—researchers from Dalhousie University
HQ Team December 16, 2024: The 2023 World Air Quality Report, released by Swiss air quality technology company IQAir, revealed that only seven
Bharti Jayshankar December 16, 2024: Researchers at the Rajiv Gandhi Biotechnology Centre, Kerala, delving into the molecular mechanisms of tumorigenesis by BRCA1 gene,